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The Lyssavirus genus of the family
Rhabdoviridae consists of five serotypes:
classical rabies virus (serotype 1), Lagos bat
virus (LBV) (serotype 2), Mokola virus
(serotype 3), Duvenhage virus (DUVV)
(serotype 4), and European bat virus (EBV)
(serotype 5). The viruses within the genus
share serologic relationships, but the sero-
types and stable species-associated variants
within serotypes can be distinguished by the
reactivity profiles of monoclonal antibodies
(Mab) directed against nucleoprotein and
glycoprotein antigens. Analysis of the
nucleotide sequence of the nucleoprotein
gene has also shown genetic clusters along
the same lines as serologic analysis, except
that serotype 5, EBV, has been separated
into two genotypes, EBV1 and EBV2 (1).
Lyssaviruses have not been isolated in
Australia before, although rhabdoviruses in
the genus Ephemerovirus are present, and
viruses with some serologic relationship to
the Lyssavirus genus, for example Adelaide
River virus (2), have been identified but not
characterized. All members of the Lyssavirus
genus can cause rabies or rabies-like
diseases in infected animals.
Rabies-like disease has been recorded in
bats on all continents except Australia.
Classical rabies virus infections are common
in insectivorous and hematophagous bats
and less common in frugivorous bats in the
Americas, while rabies-related viruses (EBV
1 and 2) are found in insectivorous bats in
Europe. Two other rabies-related viruses,
LBV and DUVV, are found in frugivorous
bats and insectivorous bats, respectively, on
the African continent. Rabies has been
described in a flying fox (Pteropus
poliocephalus) in India, although the virus
causing the disease was not characterized
(3). An outbreak of rabies involving several
dogs occurred in the Australian island state
of Tasmania in 1867 but was quickly
eradicated (4). Two cases of rabies in
children were reported in Australia (in 1987
and 1990). Both cases were caused by
classical rabies virus and were contracted in
endemic-disease countries (5). We report for
the first time apparent endemic–lyssavirus-
induced disease in Australia.
The four largest species of frugivorous
bats in Australia are called flying foxes and
belong to the genus Pteropus  (Order  Chirop-
tera, Suborder Megachiroptera, Family
Pteropodidae). The Australian range of the
flying foxes extends from temperate eastern
and coastal Australia into the eastern
tropics, around the tropical northern coast-
line, and down as far as the subtropical west
coast. The gray-headed flying fox (Pteropus
poliocephalus) range is the temperate and
subtropical east coast, the black flying fox (P.
alecto) inhabits primarily the subtropical
and tropical range, and the little red flying
fox (P. scapulatus) occupies the entire range
except the coolest southern areas. The fourth
species, the spectacled flying fox (P.
conspicillatus) occupies a smaller range in
tropical northeast Queensland. Large flying
fox “camps,” with possibly tens of thousands
of foxes, often contain more than one species.
Analysis of population genetic markers
shows a considerable movement of both P.
alecto and P. poliocephalus across their
geographic ranges within Australia (6). The
range of P. alecto extends to the north of
Australia into Papua New Guinea and the
eastern islands of Indonesia (7,8). Regular
patterns of movement suggest that flying
foxes move between northern Australia and
Papua New Guinea (L. Hall, pers. comm.). It
is, therefore, possible that the virus
described in this paper also extends across
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the range of these mammals outside
Australia.
The flying foxes (P. alecto) described in
this paper were wild native Australian
animals collected near Ballina, in northern
New South Wales, Australia. The first case,
in 1996, was in a 5-month-old female black
flying fox found under a fig tree, unable to fly.
It was euthanized by intravenous sodium
pentobarbitone injection. Fresh blood, lung,
kidney, and spleen were submitted for equine
morbillivirus (EMV) isolation; antibody to
EMV has been detected in P. alecto (9), and it
is conjectured that this species may be the
reservoir for EMV. Paraffin-embedded for-
malin-fixed samples, processed by standard
techniques, showed a severe nonsuppurative
encephalitis. The second case, in 1995, was
identified after a retrospective examination
of archived paraffin-embedded tissues. The
affected animal, a juvenile female of the same
species, was reported to be more aggressive
than usual, and was euthanized and necrop-
sied in a similar manner to the first.
Histologically, although encephalitis was
very mild, many eosinophilic, cytoplasmic
inclusion bodies were present in various
parts of the brain. All tests for EMV were
negative.
An indirect immunoperoxidase test for
rabies was carried out on tissues from
paraffin blocks (10) by using an antirabies
Mab (HAM) (Clone ‘HAM’, c/o Drs. R. Zanoni
and E . Peterhans, Institut für Veterinär-
Virologie, Länggasstr. 122, CH-3012, Bern
Switzerland) that gave good reactions
without background staining when used at
1:100. The 1996 bat had positive results over
wide areas of the brain, particularly in parts
of the hippocampus, the mesenchymal cells
of the trigeminal nucleus, and larger motor
neurons of the medulla oblongata. The brain
of the 1995 bat reacted strongly over all
areas. The reactions were either granular, or
characteristically, had ring formations in
large neurons. In addition, similar reactions
were seen in neuronal cytoplasms in nerve
plexuses of the gastrointestinal tract from
both bats. Electron microscopy examination
of ultrathin sections of hippocampus from
the 1996 bat showed aggregates of viral
nucleocapsids within the cytoplasm of cell
bodies. These inclusion bodies were specifi-
cally labeled with anti-rabies HAM Mab and
gold-labeled rabbit–anti-mouse.
The only fresh samples available were
blood, lung, kidney, and spleen from the 1996
bat. The blood was examined for neutralizing
antibody to rabies virus (CVS-11) by the
rapid fluorescent focus inhibition method
(11). No neutralizing antibody was detected.
Tissue homogenates (lung, kidney, and
spleen) were injected into mouse neuroblas-
toma cells, individually injected intracere-
brally into 3-week-old mice (five mice per
sample), and, as a pool of the three tissues,
injected into day-old suckling mice (two
litters, 14 mice). No virus was isolated from
cell culture after two serial passages of 4
days. One weanling mouse injected with
kidney homogenate showed hind leg paraple-
gia 16 days postinoculation. All other mice
remained normal until termination (suckling
mice at 21 days and weanling mice at 28 days
postinoculation). The affected mouse was
euthanized, and acetone-fixed smears of
brain material were positive for a lyssavirus
when tested by the Centocor fluorescein-
labeled Mab (Centocor Inc., 244 Great Valley
Park, Malvern, PA  19355, USA). Formalin-
fixed brain material showed nonsuppurative
encephalitis and was positive to the indirect
immunoperoxidase test for rabies virus by
the HAM Mab.
Polymerase chain reaction (PCR) tests
were done on nucleic acids extracted from
the brain, lung, kidney and spleen of the
1996 bat and on paraffin-embedded forma-
lin-fixed brain tissues from the 1995 and
1996 bats by using oligomers designed for
the amplification of lyssavirus N protein (12)
or for nested PCR amplification of the
nucleocapsid protein (5). Results from these
primers were consistently negative, presum-
ably because of formalin-fixation and/or
sequence heterogeneity. Therefore, another
nested PCR system was devised for the
amplification of N protein. Nucleic acids
were extracted (5) and transcribed into
cDNA by using a degenerate oligomer
NP1087 (5’ GAGAAAGAG[A/C]T[G/
T]CAAGA[A/C/T]TA. Primary PCR was done
with primers NP1087 and NP1279 (5’     CAG
AGACATATCT[G/C]C[G/T][G/T]ATGTG)
with amplification conditions of 94°C for 1
min, 37°C for 2 min, and 72°C for 2 min for 35Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases 329
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cycles. Nested PCR was done by using
primers NP1087 and NP1227 (5’    CTTCA
[C/T]C[G/T]ACC[A/T][C/T][C/T]GTTC
ATCAT) as above except that the number of
cycles was reduced to 25. PCR products were
excised and sequenced. Positive PCR ampli-
fication signals were derived from the tissue
culture virus and paraffin-embedded forma-
lin-fixed brain tissues by using primers
NP1087 and NP1227.  Sequence analysis of
these products showed that they were
identifical. Sequence comparisons were done
by using the nucleocapsid proteins of known
lyssaviruses and the virus reported in this
paper, designated pteropid lyssavirus (PLV)
(Table 1). Nucleotide sequence comparisons
showed that PLV had a 75% homology with
LBV, 75% homology with EBV-2, and 79%
with Pasteur vaccine rabies virus; at the
amino acid level, the virus was 85%
homologous with both EBV-2 and LBV (but
92% homologous with the rabies virus), 89%
with DUVV, and 93% homologous with EBV-
1 viruses. Phylogenetic analysis of both the
nucleotide and amino acid sequences (not
shown) showed that the virus is closely
related to the EBV as well as the classic
street rabies strains (12).
Brain material from the affected mouse
was repassaged by intracerebral inoculation
into 3-week-old mice, in which neurologic
signs developed 8 to 11 days postinoculation.
Examination of brain homogenate from these
mice by negative-contrast electron micros-
copy showed classical bullet-shaped rhab-
doviruses. The isolate was also passaged to
mouse neuroblastoma cells, which were
acetone-fixed and tested by indirect immun-
ofluorescence using a panel of Mabs against
various rabies and rabies-like viruses. The
CVS-11 strain of rabies was also tested for
comparison. The results (Table 2) confirm
that the isolate is a lyssavirus but is
different from previously described isolates.
Additional nucleocapsid Mab reaction pat-
terns (results not shown) indicated a unique
profile that shared the greatest number of
positive reactions with serotype 1 rabies
(CVS-11) compared with published profile
data on other viruses (15). Preliminary
testing of the isolate in a modified (incubated
3 days) rapid fluorescent focus inhibition
neutralization assay indicated that the virus
was neutralized by antisera to rabies virus
(mouse anti-Evelyn-Rokitnicki-Abelseth
[ERA] virus). The titer of the immune mouse
serum against CVS rabies virus was 1,194,
and against the bat virus, 1,640.
This is the first evidence of an endemic
lyssavirus in Australia. The isolate de-
scribed has been provisionally called pteropid
lyssavirus. The natural history of this virus
in bats in Australia needs to be investigated.
Further genetic and antigenic analyses are
Table 1. Amino acid sequences of the virus designated pteropid lyssavirus (PLV) and those of rabies
and rabies-like virusesa,b
PLVc PV 4FRA POL 8FRA AS FIN HOL NGA Genotype
PLV -
PV 92 - 1
4FRA 93 99 - 1
P O L 9 39 49 4- 5
8FRA 93 94 94 100 - 5
AS 89 90 91 95 95 - 4
F I N 8 58 78 88 78 78 4- 6
H O L 8 58 88 98 78 78 39 8- 6
N G A 8 28 28 38 58 58 57 67 7- 2
M O K 7 67 57 67 97 98 07 27 18 6 3
a Described in Ref. 13.
b Comparisons were made of cognate regions of the N protein (amino acids 298 to 426 inclusive). GenBank
accession numbers are given in brackets. PV, PV rabies virus (X03673); 4FRA, fox rabies virus (U22844); POL,
European bat virus (U22844, 8615POL, EBV1); 8FRA, European bat virus (U22845, 8918FRA, EBV1); AS, Duvenhage
virus (U22848); FIN, European bat virus (U22846, 9007FIN, EBV2); HOL, European bat virus (U22847, 9018HOL,
EBV2); NGA, Lagos bat virus (U22842), Mokola virus (U22843).
cPLV, the virus now reported, provisionally designated pteropid lyssavirus; PV, PV rabies virus (X03673); 4FRA,
fox rabies virus (U22844); POL, European bat virus (U22844, 8615POL, ELB1); 8FRA, European bat virus (U22845,
8918FRA, EBV1); AS, Duvenhage virus (U22848); Fin, European bat virus (U22846, 9007FIN, EBV2); HOL, European
bat virus (U22847, 9018HOL, EBV2); NGA, Lagos bat virus (U22842), Mokola virus (U22843).Emerging Infectious Diseases Vol. 2, No. 4—October-December 1996 330
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also needed to fully determine the relation-
ship of the virus to existing Lyssavirus
serogroups and genogroups and to confirm
its separate identity from other as yet
uncharacterized rhabdoviruses isolated in
Australia. The virus has been submitted to
the Rabies Laboratory at the Centers for
Disease Control and Prevention, Atlanta, for
further Mab profile analysis and
crossprotection studies with classical rabies
vaccines. Findings will result in a better
understanding of the public health implica-
tions of this newly emerged lyssavirus.
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HAMd lyssavirus + +
C15-2e rabies + -
62-143-1f rabies + +
62-3-1f rabies +, EBV + + -
62-146-3f rabies +, DUVV - + +
W422c Mokola +, LBV + - -
a+ indicates a positive reaction; - indicates a negative
reaction
bMonoclonal antibody were specificities indicated by
the following sources:
c (14,15); d (10); e (J Smith, pers. comm.); f (15,16)Vol. 2, No. 4—October-December 1996 Emerging Infectious Diseases 331
Dispatches
Addendum
Since this report was submitted in
September, 1996, the host and geographic
range of the virus have been extended. The
virus has been recognized by immunohis-
tochemical techniques in five bats in three
different virus isolations. Some of these bats
were from another species, (the little red
flying fox [P. scapulatus]), and from loca-
tions as far apart as 1,700 km along the
Australian east coast.